Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PASG compared with TCRX: revenue, margins and what each company keeps, and the suppliers and customers both name
PASG
Passage BIO, Inc.
Change
Mkt cap
Revenue
Revenue
TCRX
TScan Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PASG
Passage BIO, Inc.
vs
TCRX
TScan Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PASG
No earnings history for PASG.
TCRX
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▼
−0.49%
—
= implied
PASG realized, solid
TCRX realized, hatched
One scale, both sides: full bar = 1%
× = |realized| ÷ implied
Source: market data
PASG
Passage BIO, Inc.
Change
3.44
▼
−2.27%
Mkt cap
$11.1M
Revenue
$99,000
Q3 FY24
Revenue
—
TCRX
TScan Therapeutics, Inc.
Change
0.18
▲
+4.47%
Regular session
Oct 30 '26
Mkt cap
$11.8M
Revenue
$1M
Q2 FY26
Revenue
$10M
FY25
vs
Compare
Regular session
Oct 30 '26
PASG
Passage BIO, Inc.
vs
TCRX
TScan Therapeutics, Inc.
3.44
▼
−2.27%
Price
0.18
▲
+4.47%
$11.1M
Mkt cap
$11.8M
Q3 FY24
$99,000
Revenue
$1M
Q2 FY26
—
Revenue
$10M
FY25
Change
Change
PASG
3.44
▼
−2.27%
vs
TCRX
0.18
▲
+4.47%
Regular session
Oct 30 '26